Weltweit erste car-T-Therapie für solide Tumoren zugelassen: Das Jiahui International Cancer Center ermöglicht Patienten weltweit den Zugang zu dieser Behandlung PR Newswire (Press Release) 07:36 Fri, 26 Jun
AI-driven approach identifies promising new target for CAR T cell therapy News-Medical.Net 17:57 Thu, 25 Jun
Circio and Tcelltech jointly announce CAR-T cell therapy research collaboration European Pharmaceutical Manufacturer 14:37 Thu, 25 Jun
Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical Kir-car T Cell Therapy Programs PR Newswire (Press Release) 13:01 Thu, 25 Jun
Primera terapia car-T para tumores sólidos: Jicc proporciona acceso a pacientes de todo el mundo PR Newswire (Press Release) 11:46 Thu, 25 Jun
Première autorisation au monde d'un traitement par cellules car-T contre les tumeurs solides : le Centre international de cancérologie Jiahui est accessible aux patients du monde entier PR Newswire (Press Release) 11:46 Thu, 25 Jun
World's First Solid Tumor car-T Approved: Jiahui International Cancer Center Provides Access for Patients Worldwide PR Newswire (Press Release) 09:57 Wed, 24 Jun
Blocking cathepsin B protein enhances CAR T-cell therapy effectiveness Drug Target Review 12:55 Tue, 23 Jun
CARsgen wins first global approval of car T therapy for solid tumours European Pharmaceutical Review 11:33 Tue, 23 Jun
Wearable Devices May Help Detect Cytokine Release Syndrome Earlier in Patients Receiving CAR-T Therapy Newswise (Press Release) 19:29 Mon, 22 Jun
Dr. Theodore Scott Nowicki receives grant to advance novel CAR-T therapy for pediatric bone cancer Newswise (Press Release) 18:46 Mon, 22 Jun
Breakthrough: China’s First Approved Solid Tumor car-T Therapy Paves the Way for Industry Transformation China Money Network 15:35 Mon, 22 Jun
CARsgen Announces Approval of Satri-cel, the World's First car T-Cell Therapy Product for Solid Tumors PR Newswire (Press Release) 12:26 Mon, 22 Jun
AbClon, GC Biopharma partner on in vivo CAR-T using proprietary antibody Korea Biomedical Review 09:44 Wed, 17 Jun
EHA26: AvenCell’s AVC-201-01 switchable allogeneic CAR T offers early validation in AML Pharmaceutical Technology 12:05 Tue, 16 Jun
Blocking a specific protein improves CAR T-cell therapy success in patients with blood cancers News-Medical.Net 18:35 Mon, 15 Jun
Viva in vivo! At Eha, in vivo car T data continues to impress BioWorld 17:39 Mon, 15 Jun Article paywall
Dual-target CAR T therapy triggers broad immune response in brain cancer News-Medical.Net 17:34 Mon, 15 Jun
Immune Activation May Determine Success of Dual-Target CAR T Therapy in Glioblastoma Newswise (Press Release) 16:09 Mon, 15 Jun
EHA 2026: Legend Impresses With Early In Vivo CAR-T Results In Lymphoma Scrip Pharma Intelligence 10:29 Mon, 15 Jun
Curocell reports published phase 2 results for approved CAR-T therapy Korea Biomedical Review 05:20 Mon, 15 Jun
CARsgen Presents Allogeneic car T-cell Products CT0596 and CT1190B at Eha 2026 PR Newswire (Press Release) 01:19 Mon, 15 Jun
Researchers Identify Target with Potential to Improve CAR T-Cell Therapy Response in Patients with Blood Cancers Newswise (Press Release) 22:11 Fri, 12 Jun
Cytokine-armoured CAR T cells target glioblastoma while reducing treatment toxicity Drug Target Review 12:53 Fri, 12 Jun
Legend Biotech (LEGN) Is Up 6.1% After Early In Vivo CAR-T Data for LB2501 – What's Changed Simply Wall St 10:26 Fri, 12 Jun
